Burkitt Lymphoma News and Research

RSS
Burkitt Lymphoma is an aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, bowel, kidneys, ovaries, or other organs. There are three main types of Burkitt lymphoma (sporadic, endemic, and immunodeficiency related). Sporadic Burkitt lymphoma occurs throughout the world, and endemic Burkitt lymphoma occurs in Africa. Immunodeficiency-related Burkitt lymphoma is most often seen in AIDS patients.
Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

Scientists identify potential therapeutic target for aggressive lymphomas

Scientists identify potential therapeutic target for aggressive lymphomas

University of Glasgow-led study could lead to improved treatments for lymphoma, other cancers

University of Glasgow-led study could lead to improved treatments for lymphoma, other cancers

Researchers help explain how malaria infection increases children's risk of developing Burkitt's lymphoma

Researchers help explain how malaria infection increases children's risk of developing Burkitt's lymphoma

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Melbourne researchers develop new genome editing technology to kill blood cancer cells

Melbourne researchers develop new genome editing technology to kill blood cancer cells

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patrys provides update on development programme for anti-cancer product, PAT-LM1

Patrys provides update on development programme for anti-cancer product, PAT-LM1

Study: Immune-regulating molecules can trigger lymphomas

Study: Immune-regulating molecules can trigger lymphomas

Researchers discover promising new way to treat HIV-related blood cancer

Researchers discover promising new way to treat HIV-related blood cancer

Burkitt lymphoma risk after transplantation highlighted

Burkitt lymphoma risk after transplantation highlighted

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

HDL cholesterol key to fighting lymphoma

HDL cholesterol key to fighting lymphoma

Study finds important links between Pf malaria and endemic Burkitt Lymphoma

Study finds important links between Pf malaria and endemic Burkitt Lymphoma

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

Elevated c-Myc expression amplifies gene activity in tumor cells of multiple cancer types

Researchers identify subgroups of B cells in MYC-positive germinal centers

Researchers identify subgroups of B cells in MYC-positive germinal centers

Researchers identify key element in the development of Burkitt lymphoma

Researchers identify key element in the development of Burkitt lymphoma

Myc-directed repression of tristetraprolin important for development and maintenance of cancer

Myc-directed repression of tristetraprolin important for development and maintenance of cancer